• We are sorry, but NCBI web applications do not support your browser and may not function properly. More information

Table 4Baseline comparison of 11 screening strategies

Per 1,000 people offered screeningICER 2 £ per QALY gained
Cost (£)Effect (QALYs lost)
No screening£67,5005.258-
XR only£73,2605.165ED
XR, TST and BCG£73,8705.147£57,542
XR, IGT and BCG£74,2905.142£77,749
SQ only£85,2605.18SD
SQ, TST and BCG£85,7605.16SD
SQ, IGT and BCG£86,2905.155SD
XR, IGT, BCG and prophylaxis£98,5205.058£289,018
XR, TST, BCG and prophylaxis£102,9305.082SD
SQ, IGT, BCG and prophylaxis£109,2805.069SD
SQ, TST, BCG and prophylaxis£113,3305.092SD

SD – ‘simple dominance’ (options is more expensive and less effective than another option).

ED – ‘extended dominance’ (option is more expensive and less effective than a combination of two options).

2

The incremental cost per QALYs are calculated with respect to the previous non-dominated option.

The incremental cost per QALYs are calculated with respect to the previous non-dominated option.

From: Appendix K, Health Economic Models

Cover of Tuberculosis
Tuberculosis: Clinical Diagnosis and Management of Tuberculosis, and Measures for Its Prevention and Control.
NICE Clinical Guidelines, No. 117.
National Collaborating Centre for Chronic Conditions (UK); Centre for Clinical Practice at NICE (UK).
Copyright © 2006, Royal College of Physicians of London.

For 2006 original guideline text, no part of the content may be reproduced in any form (including photocopying or storing it in any medium by electronic means and whether or not transiently or incidentally to some other issue of this publication) without the written permission of the Royal College of Physicians of London. Applications for the Royal College of Physicians of London's written permission to reproduce any part of this publication should be addressed to the publisher.

For 2011 updated text, the material may be freely reproduced for educational and not-for-profit purposes. No reproduction by or for commercial organisations, or for commercial purposes, is allowed without the express written permission of NICE.

PubMed Health. A service of the National Library of Medicine, National Institutes of Health.